APA (7th ed.) Citation

M, O., T, Y., T, M., H, Y., E, N., M, T., . . . K, T. (2025). Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: A retrospective study. Journal of pharmaceutical health care and sciences, 11(1), 94. https://doi.org/10.1186/s40780-025-00501-x

Chicago Style (17th ed.) Citation

M, Ohtani, et al. "Clinical Efficacy of Casirivimab and Imdevimab in Preventing COVID-19 in the Omicron BA.5 Subvariant Epidemic: A Retrospective Study." Journal of Pharmaceutical Health Care and Sciences 11, no. 1 (2025): 94. https://doi.org/10.1186/s40780-025-00501-x.

MLA (9th ed.) Citation

M, Ohtani, et al. "Clinical Efficacy of Casirivimab and Imdevimab in Preventing COVID-19 in the Omicron BA.5 Subvariant Epidemic: A Retrospective Study." Journal of Pharmaceutical Health Care and Sciences, vol. 11, no. 1, 2025, p. 94, https://doi.org/10.1186/s40780-025-00501-x.